In a new job - November 20, 2022
Dignitana hires Head of Operations R&D
The company has named Johan Johansson as Vice President of Operations, Research and Development. He begins the role immediately at the company’s headquarters in Lund. “Johan brings not only proven success in Operations, Research and Development, but also specific experience with devices for temperature management as well as side effects of chemotherapy. This expertise aligns […]
In a new job - November 1, 2022
She is the new CSO at XNK Therapeutics
XNK Therapeutics has announced the appointment of Anna-Karin Maltais as Chief Scientific Officer. She will be a member of the company’s management team. “At XNK, Anna-Karin’s experience in research and development will be invaluable as the company continues to grow into new indications,” says Johan Liwing, CEO of XNK Therapeutics. “We are very happy to […]
In a new job - October 7, 2022
Per Norlén is the new CEO of Evaxion
Evaxion Biotech has announced that its new Chief Executive Officer (CEO) Per Norlén has joined the company on October 3rd. “With Per at the steering wheel, we expect to bring our promising clinical and preclinical results to the next level. Evaxion is a profoundly innovative and talented company working tirelessly to save patients’ lives. Per […]
In a new job - October 1, 2022
She is the new Managing Director of EIT Health Scandinavia
Annika Szabo has been appointed Managing Director of EIT Health Scandinavia. Annika Szabo has been Interim Managing Director at the organization since December 2021. She began working at EIT Health Scandinavia in December 2018 as Education Lead, responsible for promoting innovative education. She has also worked with the EIT Health project Healthcare Transformation Academy, run by […]
In a new job - October 1, 2022
SwedenBIO appoints International Director
Marjo Puumalainen has been appointed SwedenBIO’s first International Director, as part of the organization’s ongoing efforts to strengthen its representation of Swedish life science on the global arena. “Sweden and the Nordics have positioned ourselves internationally as a strong life science region during the pandemic. As an industry organization, it falls on us at SwedenBIO […]
In a new job - October 1, 2022
Ilya Pharma appoints CEO of its recent acquisition Nordic Bioanalysis
Ilya Pharma has appointed Leo Groenewegen as CEO of its recent acquisition Nordic Bioanalysis. Founded in 2010, Nordic Bioanalysis (NBAB) have established a strong reputation both in the Nordics and internationally as experts in bioanalytical development and validation for pharmaceuticals, classic small molecules and biologics including antibodies as well as Advanced Therapy Medicinal Products (ATMPs) […]
